CVRx Inc CVRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/24/22 EDT
7.02UNCH (UNCH)
Volume
111,977
Close
7.02quote price arrow up+0.37 (+5.56%)
Volume
1,035,455
52 week range
4.60 - 29.00
Loading...
  • Open6.75
  • Day High7.18
  • Day Low6.26
  • Prev Close7.02
  • 52 Week High29.00
  • 52 Week High Date06/30/21
  • 52 Week Low4.60
  • 52 Week Low Date04/19/22

Key Stats

  • Market Cap143.91M
  • Shares Out20.50M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-42.6

KEY STATS

  • Open6.75
  • Day High7.18
  • Day Low6.26
  • Prev Close7.02
  • 52 Week High29.00
  • 52 Week High Date06/30/21
  • 52 Week Low4.60
  • 52 Week Low Date04/19/22
  • Market Cap143.91M
  • Shares Out20.50M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-42.6

RATIOS/PROFITABILITY

  • EPS (TTM)-2.75
  • P/E (TTM)-2.56
  • Fwd P/E (NTM)-3.24
  • EBITDA (TTM)-31.43M
  • ROE (TTM)-
  • Revenue (TTM)14.25M
  • Gross Margin (TTM)73.88%
  • Net Margin (TTM)-311.83%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date09/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CVRx Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. The Company's platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure (HF) and other cardiovascular diseases. Barostim provides...
Nadim Yared
President, Chief Executive Officer, Director
Jared Oasheim
Chief Financial Officer
Craig Palmer
Vice President - US Sales
Dean Bruhn-Ding
Vice President - Regulatory Affairs and Quality Assurance
Liz Galle
Vice President - Global Clinical Research
Address
9201 West Broadway Avenue, Suite 650
Minneapolis, MN
55445
United States

Top Peers

SYMBOLLASTCHG%CHG
AXDX
Accelerate Diagnostics Inc
1.36+0.20+17.24%
DRIO
DarioHealth Corp
5.31+0.10+1.92%
ASXC
Asensus Surgical Inc
0.4173-0.0157-3.6259%
KRMD
Repro Med Systems Inc
2.43-0.02-0.82%
STXS
Stereotaxis Inc
1.99-0.11-5.24%